Brightsurf Science News & Current Events

September 19, 2009
Hormone replacement therapy increases risk of death from lung cancer
Hormone replacement therapy using estrogen and progestin increases the risk of death from lung cancer.

Lung cancer survival improved by maintenance therapy with pemetrexed
Giving pemetrexed maintenance therapy to patients with non-small-cell lung cancer who have not had disease progression after initial platinum-based chemotherapy improves both overall and progression-free survival.

Combining 2 anti-cancer drugs improves remission rates in patients with primary central nervous system lymphoma
Combining cytarabine with conventional monochemotherapy (high-dose methotrexate) improves remission rates in patients with primary central nervous system lymphoma (primary CNS lymphoma).

Dose-dense chemotherapy improves both overall and progression-free survival in advanced ovarian cancer
Women given a more intensive
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.